Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer

Condition:   HER2-positive Breast Cancer Interventions:   Drug: Pyrotinib;   Drug: Placebo Oral Tablet;   Drug: Trastuzumab;   Drug: Docetaxel Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials